4/10
12:05 pm
vrtx
Vertex Pharmaceuticals (VRTX) was given a new $612.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) was given a new $612.00 price target by Morgan Stanley. They now have an "overweight" rating on the stock.
4/8
10:38 pm
vrtx
Vertex Pharmaceuticals (VRTX) Valuation Check After FDA Expands ALYFTREK And TRIKAFTA Use [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Valuation Check After FDA Expands ALYFTREK And TRIKAFTA Use [Yahoo! Finance]
4/6
04:00 pm
vrtx
Vertex to Announce First Quarter 2026 Financial Results on May 4th
Low
Report
Vertex to Announce First Quarter 2026 Financial Results on May 4th
4/2
08:09 pm
vrtx
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note [Yahoo! Finance]
4/2
02:16 pm
vrtx
Vertex Pharmaceuticals: Label Expansions For ALYFTREK And TRIKAFTA Plus Strong Demand [Seeking Alpha]
Low
Report
Vertex Pharmaceuticals: Label Expansions For ALYFTREK And TRIKAFTA Plus Strong Demand [Seeking Alpha]
4/1
04:38 pm
vrtx
Vertex Expands Cystic Fibrosis Reach As Kidney Drug Nears FDA Decision [Yahoo! Finance]
Low
Report
Vertex Expands Cystic Fibrosis Reach As Kidney Drug Nears FDA Decision [Yahoo! Finance]
4/1
08:27 am
vrtx
Vertex Pharma wins FDA label expansion for cystic fibrosis therapies [Seeking Alpha]
Low
Report
Vertex Pharma wins FDA label expansion for cystic fibrosis therapies [Seeking Alpha]
4/1
08:24 am
vrtx
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States [Yahoo! Finance]
Low
Report
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States [Yahoo! Finance]
4/1
07:30 am
vrtx
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
Low
Report
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
3/28
03:43 am
vrtx
Wells Fargo Raises Vertex Pharmaceuticals (VRTX) Price Target to $550 [Yahoo! Finance]
Low
Report
Wells Fargo Raises Vertex Pharmaceuticals (VRTX) Price Target to $550 [Yahoo! Finance]
3/27
04:37 am
vrtx
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds [Yahoo! Finance]
Medium
Report
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds [Yahoo! Finance]
3/26
05:49 am
vrtx
Vertex Pharmaceuticals (VRTX) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
Vertex Pharmaceuticals (VRTX) was upgraded by Truist Financial Corporation to "strong-buy".
3/25
04:32 pm
vrtx
Where Will Vertex Pharmaceuticals Be in 1 Year? [Yahoo! Finance]
Low
Report
Where Will Vertex Pharmaceuticals Be in 1 Year? [Yahoo! Finance]
3/24
04:39 pm
vrtx
Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now? [Yahoo! Finance]
Low
Report
Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now? [Yahoo! Finance]
3/23
01:22 am
vrtx
How The Vertex Pharmaceuticals (VRTX) Story Is Shifting Toward Nephrology And Beyond Cystic Fibrosis [Yahoo! Finance]
Low
Report
How The Vertex Pharmaceuticals (VRTX) Story Is Shifting Toward Nephrology And Beyond Cystic Fibrosis [Yahoo! Finance]
3/22
03:30 pm
vrtx
How Vertex's IgA Nephropathy Data and Accelerated FDA Pathway At Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story [Yahoo! Finance]
Low
Report
How Vertex's IgA Nephropathy Data and Accelerated FDA Pathway At Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story [Yahoo! Finance]
3/20
06:58 am
vrtx
My Top 3 Drug Stocks for March 2026 [Yahoo! Finance]
Low
Report
My Top 3 Drug Stocks for March 2026 [Yahoo! Finance]
3/19
09:29 pm
vrtx
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Positive RAINIER Trial Update And Accelerated IgAN Filing [Yahoo! Finance]
Low
Report
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Positive RAINIER Trial Update And Accelerated IgAN Filing [Yahoo! Finance]
3/18
09:44 am
vrtx
Block upgraded, Starbucks downgraded: Wall Street's top analyst calls [Yahoo! Finance]
Low
Report
Block upgraded, Starbucks downgraded: Wall Street's top analyst calls [Yahoo! Finance]
3/18
09:33 am
vrtx
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks [Yahoo! Finance]
Low
Report
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks [Yahoo! Finance]
3/18
08:43 am
vrtx
Vertex Pharmaceuticals (VRTX) was upgraded by Maxim Group from "hold" to "buy". They now have a $575.00 price target on the stock.
Low
Report
Vertex Pharmaceuticals (VRTX) was upgraded by Maxim Group from "hold" to "buy". They now have a $575.00 price target on the stock.
3/15
09:44 pm
vrtx
Is Vertex Pharmaceuticals Heading to $600? [Yahoo! Finance]
Low
Report
Is Vertex Pharmaceuticals Heading to $600? [Yahoo! Finance]
3/14
08:40 pm
vrtx
Vertex Data Sharpen Focus On Kidney And Pain Revenue Mix [Yahoo! Finance]
Low
Report
Vertex Data Sharpen Focus On Kidney And Pain Revenue Mix [Yahoo! Finance]
3/13
12:14 pm
vrtx
This Stock Just Jumped By 8%: Is It Too Late to Buy? [Yahoo! Finance]
Low
Report
This Stock Just Jumped By 8%: Is It Too Late to Buy? [Yahoo! Finance]
3/13
10:06 am
vrtx
2 Reasons to Watch VRTX and 1 to Stay Cautious [Yahoo! Finance]
Low
Report
2 Reasons to Watch VRTX and 1 to Stay Cautious [Yahoo! Finance]